Drugs / Yinqiaosan-Maxingganshitang
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05787327 | May 2023 → Apr 2024 | COVID-19 | Chinese University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yinqiaosan-Maxingganshitang | “Active treatment (Yinqiaosan-Maxingganshitang )” NCT05787327 ↗ |